The export of traditional Chinese medicine will continue to accelerate, and traditional Chinese medicine enterprises will usher in a period of development opportunities

[Pharmaceutical Network Market Analysis] In recent years, with the continuous support and promotion of the traditional Chinese medicine industry from the state to the local, and the continuous improvement of the acceptance of traditional Chinese medicine in overseas markets, the export of Chinese medicinal materials and traditional Chinese medicine products in China has continued to grow, and new markets have also In continuous developme.
For example, according to the statistics of Bozhou Customs, in 2021, Bozhou will export 15,000 tons of Chinese medicinal materials and Chinese patent medicines, worth 510 million yuan, accounting for 62% of the total export value of Chinese medicinal materials in Anhui Provin.
In the first two months of this year, Bozhou exported 1,876 tons of Chinese herbal medicines and Chinese-&g.
At present, all parts of the country are still stepping up to formulate a blueprint for the development of the Chinese medicine industry in the futu.
Among them, the overseas Chinese medicine has obviously become a key task in many plac.
For example, Guangxi proposed that during the "14th Five-Year Plan" period, it will strive to create a national export base of traditional Chinese medicine services, explore the development of "Internet + traditional Chinese medicine trade", build a medicinal material trade processing zone by relying on ports, expand and strengthen the professional market for traditional Chinese medicinal materials, and create China-ASEAN trade channel of traditional Chinese medicine and traditional medici.
It is understood that Guangxi is actually a province with large resources of traditional Chinese medicine in Chi.
As a frontier window for China's opening-up and cooperation with ASEAN, Guangxi has now formed a pattern of opening-up and cooperation in the field of traditional Chinese medicine, mainly from ASEAN countries and Hong Kong, Macao and Taiwan, covering more than 40 countries and regio.
At present, Guangxi has gradually become the main channel for the import of ASEAN Chinese medicinal materia.
The variety and quantity of ASEAN Chinese medicinal materials entering customs through Guangxi ports have grown rapid.
Since 2020, the total value of goods has ranked among the top in China for two consecutive yea.
Traditional Chinese medicine carries the history of China for five thousand years and has attracted worldwide attenti.
Especially in recent years, traditional Chinese medicine has made great contributions to the protection of people's heal.
In this regard, the industry generally believes that the overall Chinese medicine market will show a steady growth trend in the future, and the overseas market will also continue to accelera.
In fact, with the help of a series of policies, the traditional Chinese medicine industry is showing more and more promising overseas development prospec.
It is understood that at the beginning of this year, the state issued the "Development Plan for Promoting the High-quality Integration of Traditional Chinese Medicine into the Belt and Road Initiative (2021-2025.
The plan proposes that during the "14th Five-Year Plan" period, 30 high-quality Chinese medicine overseas centers will be built in cooperation with the "Belt and Road" countries to provide high-quality Chinese medicine services to the people of the "Belt and Road" countri.

In addition, the General Office of the State Council also issued the "14th Five-Year Plan for the Development of Traditional Chinese Medicine" in March, which clearly proposed to build a high-level traditional Chinese medicine inheritance protection and technological innovation system, promote the high-quality development of the traditional Chinese medicine industry, and develop the traditional Chinese medicine health service indust.

, speed up the opening and development of traditional Chinese medicine and other ten tas.

The industry believes that in 2022, with the support of policies and medical insurance, the Chinese medicine industry is expected to usher in an upward turning point, and traditional Chinese medicine companies will fully embrace the market and usher in a period of inheritance and development opportuniti.

At the same time, the innovation of proprietary Chinese medicines and the export of proprietary Chinese medicines will also become key research areas in the futu.

Affected by this, the overseas market of traditional Chinese medicine will continue to accelerate and usher in more new breakthroug.

Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyo.